Email this article 
Post a Comment Higher-dose canakinumab therapy for refractory macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: two case reports - PDF (Russian)
Copyright (c) 2014 Kostik M.M., Likhacheva T.S., Chikova I.A., Buchinskaya N.V., Abramova N.N., Kalashnikova O.V., Cron R.Q., Chasnyk V.G.
This work is licensed under a Creative Commons Attribution 4.0 International License.